A Study Of Artificial Intelligence Virtual Assistant For Breast Cancer Patients And Survivors

Overview

About this study

The purpose of this study is to determine the effects of a novel AIVA for breast cancer patients and survivors on health care utilization compared to the control group. Our working hypothesis is that breast cancer patients and survivors undergoing reconstructive breast surgery, who leverage our novel AIVA tool, will have reduced clerical resource utilization compared to those receiving standard of care postoperative instructions alone

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 Years of Age
  • English-speaking 
  • Breast cancer patients undergoing reconstructive surgery

Exclusion Criteria:

  • Adults unable to consent, those with cognitive impairment, and anyone with conditions affecting their ability to interact with the virtual assistant system

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/26/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Antonio Forte, M.D., Ph.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions